Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment, covering 2024-05-02 to 2024-05-02. Get the full timeline:
Most recent: Clinical Trial Update: A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome. [Phase 1]